Parametric Portfolio Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $762M | Buy |
|
|||||
|
2021
Q4 | $606M | Sell |
|
|||||
|
2021
Q3 | $584M | Buy |
|
|||||
|
2021
Q2 | $645M | Buy |
|
|||||
|
2021
Q1 | $593M | Buy |
|
|||||
|
2020
Q4 | $571M | Buy |
|
|||||
|
2020
Q3 | $524M | Sell |
|
|||||
|
2020
Q2 | $511M | Buy |
|
|||||
|
2020
Q1 | $456M | Buy |
|
|||||
|
2019
Q4 | $484M | Buy |
|
|||||
|
2019
Q3 | $234M | Buy |
|
|||||
|
2019
Q2 | $188M | Buy |
|
|||||
|
2019
Q1 | $189M | Sell |
|
|||||
|
2018
Q4 | $217M | Buy |
|
|||||
|
2018
Q3 | $247M | Buy |
|
|||||
|
2018
Q2 | $208M | Sell |
|
|||||
|
2018
Q1 | $249M | Buy |
|
|||||
|
2017
Q4 | $227M | Buy |
|
|||||
|
2017
Q3 | $215M | Buy |
|
|||||
|
2017
Q2 | $174M | Buy |
|
|||||
|
2017
Q1 | $158M | Sell |
|
|||||
|
2016
Q4 | $187M | Buy |
|
|||||
|
2016
Q3 | $159M | Sell |
|
|||||
|
2016
Q2 | $262M | Buy |
|
|||||
|
2016
Q1 | $219M | Buy |
|
|||||
|
2015
Q4 | $231M | Buy |
|
|||||
|
2015
Q3 | $188M | Sell |
|
|||||
|
2015
Q2 | $229M | Buy |
|
|||||
|
2015
Q1 | $221M | Buy |
|
|||||
|
2014
Q4 | $192M | Buy |
|
|||||
|
2014
Q3 | $154M | Buy |
|
|||||
|
2014
Q2 | $139M | Sell |
|
|||||
|
2014
Q1 | $149M | Buy |
|
|||||
|
2013
Q4 | $150M | Buy |
|
|||||
|
2013
Q3 | $121M | Buy |
|
|||||
|
2013
Q2 | $116M | Buy |
|